Arkolith/Insider Trading/ADPT/Form 4

Rubinstein Julie

President and COOAdaptive Biotechnologies Corp (ADPT) · full profile →Form 4 · filed Apr 16, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$826K
Net Open-Market Flow
-$826K
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 16, 2026Option exercise(M)15K$8.46$125K427K
Apr 16, 2026Sell(S)19K$14.18$270K408K
Apr 15, 2026Option exercise(M)15K$8.46$125K432K
Apr 15, 2026Sell(S)19K$14.61$278K412K
Apr 14, 2026Option exercise(M)15K$8.46$125K436K
Apr 14, 2026Sell(S)19K$14.56$278K417K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 16, 2026Option exercise(M)15K—$0149K
Apr 15, 2026Option exercise(M)15K—$0163K
Apr 14, 2026Option exercise(M)15K—$0178K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001780664-26-000026) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML